VEMURAFENIB IN TREATMENT OF MELANOMA WITH BRAIN METASTASES

VEMURAFENIB IN TREATMENT OF MELANOMA WITH BRAIN METASTASES

The effectiveness of traditional chemotherapy (with temozolomide, fotemustine, lomustine) alone or in combination with whole brain radiotherapy in melanoma patients with cerebral metastases does not exceed 7–10  % with no significant impact on survival, which is around 2–4  months. Targeted therapy...

Full description

Bibliographic Details
Main Authors: D. R. Naskhletashvili, V. A. Gorbunova, A. Kh. Bekyashev, L. V. Demidov, G. Yu. Kharkevich, S. M. Banov, I. V. Samoylenko, K. А. Baryshnikov, K. V. Orlova, I. А. Utyashev, N. N. Petenko, I. G. Markina, E. A. Moskvina, S. V. Medvedev
Format: Article
Language:Russian
Published: ABV-press 2017-04-01
Series:Opuholi Golovy i Šei
Subjects:
vemurafenib
melanoma
brain metastases
targeted therapy
Online Access:https://ogsh.abvpress.ru/jour/article/view/248

Similar Items

Similar Items